Anticorps Polyclonal de lapin anti-GPD1
GPD1 Polyclonal Antibody for WB, IF/ICC, Indirect ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IF/ICC, Indirect ELISA
Conjugaison
Non conjugué
N° de cat : 13451-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
13451-1-PBS cible GPD1 dans les applications de WB, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris | 
| Hôte / Isotype | Lapin / IgG | 
| Clonalité | Polyclonal | 
| Type | Anticorps | 
| Immunogène | GPD1 Protéine recombinante Ag4278 | 
| Nom complet | glycerol-3-phosphate dehydrogenase 1 (soluble) | 
| Masse moléculaire calculée | 349 aa, 38 kDa | 
| Poids moléculaire observé | 32-42 kDa | 
| Numéro d’acquisition GenBank | BC032234 | 
| Symbole du gène | GPD1 | 
| Identification du gène (NCBI) | 2819 | 
| Conjugaison | Non conjugué | 
| Forme | Liquide | 
| Méthode de purification | Purification par affinité contre l'antigène | 
| Tampon de stockage | PBS only | 
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. | 
Informations générales
GPD1 (Glycerol-3-phosphate dehydrogenase 1) is an important enzyme belonging to the NAD-dependent glycerol-3-phosphate dehydrogenase family. Its C-terminal structural domain contains multiple helical structures for binding the substrate DHAP, and its N-terminal structural domain contains a β-folded core for binding NADH. GPD1 catalyzes the conversion of dihydroxyacetone phosphate (DHAP) and reduced nicotinamide adenine dinucleotide (NADH) to glycerol-3-phosphate (G3P) and NAD+, and plays a key role in carbohydrate and lipid metabolism. GPD1 also works with mitochondrial glycerol-3-phosphate dehydrogenase to form a glycerophosphate shuttle system that facilitates the transfer of reducing equivalents from the cytoplasm to the mitochondria. Abnormal activity of GPD1 has been associated with a variety of metabolic disorders, such as obesity, hypertriglyceridemia, and GPD1 has been implicated in cancer, potentially acting as a tumor suppressor.







